Tachibana K - Search Results

1

Modifying the blood-brain barrier by targeting claudin-5: Safety and risks.

Wakayama E, Kuzu T, Tachibana K, Hirayama R, Okada Y, Kondoh M. Wakayama E, et al. Among authors: tachibana k. Ann N Y Acad Sci. 2022 Aug;1514(1):62-69. doi: 10.1111/nyas.14787. Epub 2022 May 4. Ann N Y Acad Sci. 2022. PMID: 35508916 Review.

2

Ubiquitination of Lysine 867 of the Human SETDB1 Protein Upregulates Its Histone H3 Lysine 9 (H3K9) Methyltransferase Activity.

Ishimoto K, Kawamata N, Uchihara Y, Okubo M, Fujimoto R, Gotoh E, Kakinouchi K, Mizohata E, Hino N, Okada Y, Mochizuki Y, Tanaka T, Hamakubo T, Sakai J, Kodama T, Inoue T, Tachibana K, Doi T. Ishimoto K, et al. Among authors: tachibana k. PLoS One. 2016 Oct 31;11(10):e0165766. doi: 10.1371/journal.pone.0165766. eCollection 2016. PLoS One. 2016. PMID: 27798683 Free PMC article.

3

Degradation of human Lipin-1 by BTRC E3 ubiquitin ligase.

Ishimoto K, Hayase A, Kumagai F, Kawai M, Okuno H, Hino N, Okada Y, Kawamura T, Tanaka T, Hamakubo T, Sakai J, Kodama T, Tachibana K, Doi T. Ishimoto K, et al. Among authors: tachibana k. Biochem Biophys Res Commun. 2017 Jun 17;488(1):159-164. doi: 10.1016/j.bbrc.2017.04.159. Epub 2017 May 5. Biochem Biophys Res Commun. 2017. PMID: 28483528

4

The Clinical Innovation Network: a policy for promoting development of drugs and medical devices in Japan.

Matsushita S, Tachibana K, Kondoh M. Matsushita S, et al. Among authors: tachibana k. Drug Discov Today. 2019 Jan;24(1):4-8. doi: 10.1016/j.drudis.2018.05.026. Epub 2018 May 24. Drug Discov Today. 2019. PMID: 29803934 Review.

5

Anti-Claudin Antibodies as a Concept for Development of Claudin-Directed Drugs.

Hashimoto Y, Okada Y, Shirakura K, Tachibana K, Sawada M, Yagi K, Doi T, Kondoh M. Hashimoto Y, et al. Among authors: tachibana k. J Pharmacol Exp Ther. 2019 Feb;368(2):179-186. doi: 10.1124/jpet.118.252361. Epub 2018 Dec 7. J Pharmacol Exp Ther. 2019. PMID: 30530622 Review.

6

Lipin-1 is a novel substrate of protein phosphatase PGAM5.

Okuno H, Okuzono H, Hayase A, Kumagai F, Tanii S, Hino N, Okada Y, Tachibana K, Doi T, Ishimoto K. Okuno H, et al. Among authors: tachibana k. Biochem Biophys Res Commun. 2019 Feb 19;509(4):886-891. doi: 10.1016/j.bbrc.2019.01.031. Epub 2019 Jan 11. Biochem Biophys Res Commun. 2019. PMID: 30642635

7

A Review of the Regulatory Framework for Initiation and Acceleration of Patient Access to Innovative Medical Products in Japan.

Matsushita S, Tachibana K, Nakai K, Sanada S, Kondoh M. Matsushita S, et al. Among authors: tachibana k. Clin Pharmacol Ther. 2019 Sep;106(3):508-511. doi: 10.1002/cpt.1383. Epub 2019 Mar 18. Clin Pharmacol Ther. 2019. PMID: 30883696 No abstract available.

8

Potential for Tight Junction Protein-Directed Drug Development Using Claudin Binders and Angubindin-1.

Hashimoto Y, Tachibana K, Krug SM, Kunisawa J, Fromm M, Kondoh M. Hashimoto Y, et al. Among authors: tachibana k. Int J Mol Sci. 2019 Aug 17;20(16):4016. doi: 10.3390/ijms20164016. Int J Mol Sci. 2019. PMID: 31426497 Free PMC article. Review.

9

A Method to Prepare Claudin-Modulating Recombinant Proteins.

Tachibana K, Kondoh M. Tachibana K, et al. Methods Mol Biol. 2020;2109:251-260. doi: 10.1007/7651_2019_258. Methods Mol Biol. 2020. PMID: 31471875

10

A Concept for a Japanese Regulatory Framework for Emerging Medical Devices with Frequently Modified Behavior.

Ota N, Tachibana K, Kusakabe T, Sanada S, Kondoh M. Ota N, et al. Among authors: tachibana k. Clin Transl Sci. 2020 Sep;13(5):877-879. doi: 10.1111/cts.12784. Epub 2020 Apr 3. Clin Transl Sci. 2020. PMID: 32216078 Free PMC article. Review.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

1,035 results

Search Page